Drug Pipeline

Leflunomide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
2
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT06714461
A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA®…		 Trial completed
2026-06-12 NCT06714461
A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA®…		 Enrollment reduced: 3500 -> 302 participants
Active Studies by Phase
Phase 2
2
Phase 1/2
1
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04508790 Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory… Recurrent Plasma Cell Myeloma Recruiting
NCT05014646 Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in… Smoldering Plasma Cell Myeloma Active, Not Recruiting
Phase 1/2
NCT06923488 Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory… Myelodysplastic Syndromes Recruiting
Phase 1
NCT06454383 Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer Advanced Pancreatic Adenocarcinoma Recruiting
Early Phase 1
NCT04370483 Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma Smoldering Plasma Cell Myeloma Active, Not Recruiting
Sponsors Running Leflunomide Trials
City of Hope Medical Center (4) West Virginia University (1)
Disease Areas
Multiple Myeloma (3) Pancreatic Cancer (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Leflunomide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free